Kissei Pharmaceutical Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	15,610	14,449	13,680	16,507	7,476
Depreciation & Amortization	4,615	4,254	4,109	3,730	3,148
Loss (Gain) From Sale of Assets	3,110	-80	-63	35	10
Loss (Gain) From Sale of Investments	-11,999	-9,119	-13,133	-16,161	-4,727
Other Operating Activities	-4,427	-1,893	-5,799	-2,672	-769
Change in Accounts Receivable	-974	-5,863	27	250	-3,595
Change in Inventory	1,316	-3,480	-3,810	1,130	-6,679
Change in Accounts Payable	-291	275	513	-3,804	2,671
Change in Other Net Operating Assets	-439	-220	-2,203	2,518	-77
Operating Cash Flow	6,521	-1,677	-6,679	1,533	-2,542
Capital Expenditures	-4,507	-1,201	-2,103	-1,489	-931
Sale of Property, Plant & Equipment	519	175	78	23	3
Sale (Purchase) of Intangibles	-523	-632	-444	-430	-554
Investment in Securities	13,091	9,502	13,031	16,391	790
Other Investing Activities	-3,627	844	-4,564	-3,741	-8,669
Investing Cash Flow	4,952	8,690	6,001	10,776	-9,329
Short-Term Debt Issued	170	-	-	-	-
Total Debt Issued	170	-	-	-	-
Short-Term Debt Repaid	-230	-150	-150	-90	-
Long-Term Debt Repaid	-	-	-	-13	-16
Total Debt Repaid	-230	-150	-150	-103	-16
Net Debt Issued (Repaid)	-60	-150	-150	-103	-16
Repurchase of Common Stock	-5,293	-6,000	-	-	-1,303
Common Dividends Paid	-3,801	-3,722	-3,135	-2,536	-2,475
Other Financing Activities	-171	-134	-135	-117	-206
Financing Cash Flow	-9,325	-10,006	-3,420	-2,756	-4,000
Foreign Exchange Rate Adjustments	27	-3	-21	4	-
Miscellaneous Cash Flow Adjustments	96	-1	-1	-	-1
Net Cash Flow	2,271	-2,997	-4,120	9,557	-15,872
Free Cash Flow	2,014	-2,878	-8,782	44	-3,473
Free Cash Flow Margin	2.28%	-3.81%	-13.01%	0.07%	-5.03%
Free Cash Flow Per Share	46.17	-63.59	-190.44	0.95	-74.42
Cash Interest Paid	22	18	20	23	23
Cash Income Tax Paid	4,357	1,834	5,699	2,567	652
Levered Free Cash Flow	2,448	200.38	-7,654	3,843	-7,691
Unlevered Free Cash Flow	2,461	211.63	-7,641	3,858	-7,677
Change in Working Capital	-388	-9,288	-5,473	94	-7,680

Source: S&P Global Market Intelligence. Standard template. Financial Sources.